Dolby Laboratories, Inc. DLB Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $95.45M+3.5% | $53.68M-21.1% | $49.65M-15.6% | $46.54M+17.4% | $92.23M-6.1% | ||
| $24.1M+11.9% | $24.15M+8.0% | $22M+3.0% | $21.93M+19.8% | $21.54M+19.5% | ||
| $30.71M+0.1% | $37.21M+3.2% | $31.05M+4.6% | $30.73M+4.7% | $30.66M+6.0% | ||
| $5.2M+45.7% | $16K+100% | $14.13M+492% | -$5.41M+51.9% | $3.57M+358% | ||
| $2.9M+134% | $792K+8.5% | $0— | $615K+166% | $1.24M— | ||
| $21.13M— | $82.96M+237% | $33.7M+341% | -$15.65M-657% | —— | ||
| -$2.97M-219% | -$879K+34.4% | -$4M— | -$5.18M— | $2.5M— | ||
| $39.3M+74.9% | $43.58M+807% | $71.83M— | -$76.25M+10.0% | $22.46M-37.5% | ||
| $30.69M+335% | $3.15M+123% | —— | -$20.4M-178% | -$13.05M+52.8% | ||
| -$9.19M-0.4% | -$3.03M+15.3% | —— | —— | -$9.16M+33.0% | ||
| —— | $1.89M+259% | —— | $17.11M+365% | $1.63M+116% | ||
| $650K+259% | $6.83M+85.0% | -$4.02M+38.6% | -$4.34M+25.6% | -$409K-111% | ||
| -$10.46M— | $4.39M-71.3% | -$44.72M-126% | —— | —— | ||
| $2.75M-4.9% | $2.67M-5.9% | $2.58M-14.8% | $2.47M-14.8% | $2.89M+4.7% | ||
| $9.48M+294% | $1.55M+294% | -$266K+90.1% | -$2.56M+29.1% | -$4.88M-192% | ||
| —— | $5.28M+479% | —— | —— | $414K-18.1% | ||
| $92.51M-47.1% | $54.8M-48.7% | $122.83M+5.7% | $67.69M+218% | $174.9M-3.6% | ||
| $9.06M+31.4% | $4.63M-31.7% | $16.24M+120% | $6.43M-15.6% | $6.9M-22.6% | ||
| $0— | $0-100% | —— | —— | —— | ||
| —— | —— | —— | —— | $15.91M+393% | ||
| —— | $6.62M— | —— | —— | $0— | ||
| -$46.09M-278% | $1.25M+115% | -$21.91M+91.6% | -$6.43M+17.0% | $25.9M+245% | ||
| $34.34M+7.9% | $34.34M+8.8% | $31.59M+10.4% | $31.63M+10.2% | $31.83M+10.8% | ||
| $65M+85.7% | $70.01M+367% | $35M+75.0% | $70.01M+100% | $35M+40.0% | ||
| $1.04M-73.8% | $14.25M-35.7% | $5.02M+601% | $12.56M+23.8% | $3.97M-64.1% | ||
| $559K+132% | $547K-26.1% | $398K-39.4% | $468K-86.5% | $241K— | ||
| -$99.88M-54.0% | -$121.83M-112% | -$64.06M-6.5% | -$60.74M-4.0% | -$64.87M-46.9% | ||
| -$301K— | -$5K+99.9% | —— | $5.7M— | —— | ||
| -$53.76M-139% | -$65.8M-294% | $36.8M+118% | $6.22M+114% | $138.69M+19.9% | ||
| $32.01M-2.8% | $11.65M+9.8% | $15.22M+22.2% | $14.97M+22.9% | $32.94M+22.8% | ||
| —— | —— | $0— | $0— | $0— | ||
| —— | $5.28M+479% | —— | —— | $414K-18.1% | ||
| $40.65M+330% | $19.82M-15.3% | -$23.58M-36,380% | -$25.96M— | $9.45M-63.1% | ||
| $9.48M+294% | $1.55M+294% | -$266K+90.1% | -$2.56M+29.1% | -$4.88M-192% | ||
| $12.37M— | $4.81M+93.4% | $2.79M+277% | $109K— | —— | ||
| -$9.19M-0.4% | -$3.03M+15.3% | —— | —— | -$9.16M+33.0% | ||
| $30.69M+335% | $3.15M+123% | —— | -$20.4M-178% | -$13.05M+52.8% | ||
| $2.75M-4.9% | $2.67M-5.9% | $2.58M-14.8% | $2.47M-14.8% | $2.89M+4.7% | ||
| —— | $1.89M+259% | —— | $17.11M+365% | $1.63M+116% | ||
| $2.9M+134% | $792K+8.5% | $0— | $615K+166% | $1.24M— | ||
| $37.03M— | $750K— | —— | —— | $0— | ||
| —— | —— | —— | —— | $15.91M+393% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | $65.25K— | $65.25K— | $65.25K— | ||
| —— | —— | $0+100% | $0+100% | $0+100% | ||
| $1.03M-32.1% | $31.2M-3.8% | $2.08M+26.4% | $1.2M-12.4% | $1.51M+1.2% | ||
| —— | —— | $0— | $0— | $0— | ||
| —— | —— | $0+100% | $0+100% | $0+100% | ||
| —— | —— | $308.75K-81.4% | $308.75K-81.4% | $308.75K-81.4% | ||
| $9.48M+294% | $1.55M+294% | -$266K+90.1% | -$2.56M+29.1% | -$4.88M-192% | ||
| $882K+192% | $3.81M+13.5% | -$13.57M-629% | $8.34M— | -$961K-114% | ||
| —— | —— | $0— | $0— | $0— | ||
| $83.44M-50.3% | $50.17M-49.8% | $106.59M-2.0% | $61.26M+349% | $168M-2.6% | ||
| $83.44M-50.3% | $50.17M-49.8% | $106.59M-2.0% | $61.26M+349% | $168M-2.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Dolby Laboratories, Inc.'s cash flow data come from?
- Every line is extracted from Dolby Laboratories, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.